Ledger.Open graph →
SEC Form D · filed April 7, 2023

GlycosBio Inc

Offering
$1.0M
Sold
$425K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Houston, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Richard C. Cilento · Houston, TXExec · DirectorDavid Stetson · Toronto, Ontario, CanadaDirectorAndrew Lee · New York, NYDirectorRichard C. Cilento · Houston, TXExec · DirectorFrank C. Foster · Santa Barbara, CADirectorJoseph C. Walowski · Houston, TXDirectorJohn Pollesel · Toronto, Ontario, CanadaDirectorDan C. Watkins · Houston, TXDirectorGail J. Makode · Hunt Valley, MDDirectorSusumu J. Kodera · Irvine, CADirectorNic Pannekeet · Seattle, WADirectorVictoria C. Niklas · Houston, TXDirectorWayne Byrne · Seattle, WADirectorSusan Uthayakumar · Toronto, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗